Kurt R. Gehlsen
Director Técnico/Científico/I+D en Biorasi LLC .
Perfil
Kurt R.
Gehlsen is currently the Chief Scientific Officer & Vice President at Biorasi LLC.
Previously, he worked as the Chief Science Officer at Maxim Pharmaceuticals, Inc. from 1996 to 2006.
He also held a position as a Principal at the California Institute of Technology.
Dr. Gehlsen obtained his undergraduate and doctorate degrees from the University of Arizona.
Cargos activos de Kurt R. Gehlsen
| Empresas | Cargo | Inicio |
|---|---|---|
Biorasi LLC
 Biorasi LLC BiotechnologyHealth Technology Biorasi LLC operates as a contract research organization specializes in the development of therapeutics. It provides services, including program management, regulatory services, including trial approval services, interim and post trial regulatory management, and marketing approval/registration services and clinical services, including training, monitoring, and issue resolution. The company was founded by Boris N. Reznik in 2002 and is headquartered in Miami, FL. | Director Técnico/Científico/I+D | 29/01/2019 |
Antiguos cargos conocidos de Kurt R. Gehlsen.
| Empresas | Cargo | Fin |
|---|---|---|
| Maxim Pharmaceuticals, Inc. | Director Técnico/Científico/I+D | 06/01/2006 |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | Corporate Officer/Principal | - |
Formación de Kurt R. Gehlsen.
| University of Arizona | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
| Maxim Pharmaceuticals, Inc. | Health Technology |
Biorasi LLC
Biorasi LLC BiotechnologyHealth Technology Biorasi LLC operates as a contract research organization specializes in the development of therapeutics. It provides services, including program management, regulatory services, including trial approval services, interim and post trial regulatory management, and marketing approval/registration services and clinical services, including training, monitoring, and issue resolution. The company was founded by Boris N. Reznik in 2002 and is headquartered in Miami, FL. | Health Technology |
- Bolsa de valores
- Insiders
- Kurt R. Gehlsen
